Results
1 -
4 of
4
(Click
here to explore results)
- Synthesis and in vitro assessment of chemically modified siRNAs targeting BCL2 that contain 2′-ribose and triazole-linked backbone modifications. Gordon Hagen, Brandon J. Peel, John Samis, Jean-Paul Desaulniers
, Med. Chem. Commun.
, 2015
, 6
, 1210
- Antisense oligonucleotides: modifications and clinical trials. Vivek K. Sharma, Raman K. Sharma, Sunil K. Singh
, Med. Chem. Commun.
, 2014
, 5
, 1454
- Rational design and structure–activity relationship studies of quercetin–amino acid hybrids targeting the anti-apoptotic protein Bcl-xL. Tahsin F. Kellici, Maria V. Chatziathanasiadou, Min-Sung Lee, Nisar Sayyad, Elena G. Geromichalou, Eirinaios I. Vrettos, Antonis D. Tsiailanis, Seung-Wook Chi, George D. Geromichalos, Thomas Mavromoustakos, Andreas G. Tzakos
, Org. Biomol. Chem.
, 2017
, 15
, 7956
- Modified internucleoside linkages for nuclease-resistant oligonucleotides. Guillaume Clavé, Maeva Reverte, Jean-Jacques Vasseur, Michael Smietana
, RSC Chem. Biol.
, 2021
, 2
, 94